• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    1/24/24 4:05:27 PM ET
    $PAYS
    EDP Services
    Technology
    Get the next $PAYS alert in real time by email
    SC 13G/A 1 d140207dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)

     

     

    Paysign, Inc.

    (Name of Issuer)

    Common Stock, $0.001 par value

    (Title of Class of Securities)

    70451A104

    (CUSIP Number)

    January 22, 2024

    (Date of Event Which Requires Filing of Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 70451A104

     

     1   

     Names of reporting persons

     

     Topline Capital Management, LLC

     2  

     Check the appropriate box if a member of a group (see instructions)

     

     (a) ☐  (b) ☐

     3  

     SEC use only

     

     4  

     Citizenship or place of organization

     

     California

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with

       5   

     Sole voting power

     

     5,356,872

       6  

     Shared voting power

     

     0

       7  

     Sole dispositive power

     

     5,356,872

       8  

     Shared dispositive power

     

     0

     9   

     Aggregate amount beneficially owned by each reporting person

     

     5,356,872

    10  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

     ☐

    11  

     Percent of class represented by amount in Row (9)

     

     10.1%

    12  

     Type of reporting person (see instructions)

     

     IA

     

    2


    CUSIP No. 70451A104

     

     1   

     Names of reporting persons

     

     Collin McBirney

     2  

     Check the appropriate box if a member of a group (see instructions)

     

     (a) ☐  (b) ☐

     3  

     SEC use only

     

     4  

     Citizenship or place of organization

     

     USA

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with

       5   

     Sole voting power

     

     0

       6  

     Shared voting power

     

     5,356,872

       7  

     Sole dispositive power

     

     0

       8  

     Shared dispositive power

     

     5,356,872

     9   

     Aggregate amount beneficially owned by each reporting person

     

     5,356,872

    10  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

     ☐

    11  

     Percent of class represented by amount in Row (9)

     

     10.1%

    12  

     Type of reporting person (see instructions)

     

     IN/HC

     

     

    3


    CUSIP No. 70451A104

     

     1   

     Names of reporting persons

     

     Topline Capital Partners, LP

     2  

     Check the appropriate box if a member of a group (see instructions)

     

     (a) ☐  (b) ☐

     3  

     SEC use only

     

     4  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with

       5   

     Sole voting power

     

     5,356,872

       6  

     Shared voting power

     

     0

       7  

     Sole dispositive power

     

     5,356,872

       8  

     Shared dispositive power

     

     0

     9   

     Aggregate amount beneficially owned by each reporting person

     

     5,356,872

    10  

     Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

     ☐

    11  

     Percent of class represented by amount in Row (9)

     

     10.1%

    12  

     Type of reporting person (see instructions)

     

     PN

     

     

    4


    Item 1

     

      (a)

    Name of Issuer:

    Paysign, Inc.

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    2615 St. Rose Parkway, Henderson, NV 89052

     

    Item 2

     

      (a)

    Name of Persons Filing:

    Topline Capital Management, LLC (“TCM”)

    Collin McBirney

    Topline Capital Partners, LP (“TCP” or the “Fund”)

     

      (b)

    Address of Principal Business Office or, if none, Residence:

    544 Euclid Street, Santa Monica, CA 90402

     

      (c)

    Citizenship:

    Reference is made to Row 4 of pages 2 - 4 of this Schedule 13G (this “Schedule”), which are incorporated by reference herein.

     

      (d)

    Title of Class of Securities:

    Common Stock, $0.001 par value

     

      (e)

    CUSIP Number: 70451A104

     

    Item 3.

    If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

    Not applicable.

     

    Item 4.

    Ownership

    Reference is hereby made to Rows 5-9 and 11 of pages 2, 3 and 4 of this Schedule, which are incorporated by reference herein. As of January 22, 2024, the Fund beneficially owns 5,356,872 shares of the issuer’s common stock.

    The securities reported on this Schedule as beneficially owned by TCM (the “Securities”) are held by and for the benefit of the Fund. Under the definition of “beneficial ownership” in Rule 13d-3 under the Act, it is also possible that the individual general partners, executive officers, and members of the foregoing entities might be deemed the “beneficial owners” of some or all of the Securities insofar as they may be deemed to share the power to direct the voting or disposition of such Securities. TCM, as the investment manager and general partner of the Fund, and Collin McBirney, as the member-manager of TCM, may, therefore, be deemed to beneficially own the Securities held by the Fund for the purposes of Rule 13d-3 under the Act insofar as they may be deemed to have the power to direct the voting or disposition of those Securities.

    Neither the filing of this Schedule nor any of its contents shall be deemed to constitute an admission that any of TCM or Mr. McBirney is, for any other purpose, the beneficial owner of any of the Securities held by the Fund, and each of TCM and Mr.

     

    5


    McBirney expressly disclaims beneficial ownership as to the Securities held by the Fund, except to the extent of its or his pecuniary interests therein.

    The calculation of percentage of beneficial ownership in Row 11 of pages 2, 3 and 4 of this Schedule was derived from the issuer’s Form 10-Q Quarterly Report filed with the Securities and Exchange Commission on November 8, 2023, in which the issuer stated that the number of shares of its common stock outstanding as of November 3, 2023 was 52,754,374 shares.

     

    6


    Item 5.

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ☐

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

    Not applicable.

     

    Item 8.

    Identification and Classification of Members of the Group

    Not applicable.

     

    Item 9.

    Notice of Dissolution of Group

    Not applicable.

     

    Item 10.

    Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    7


    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: January 24, 2024

     

    TOPLINE CAPITAL MANAGEMENT, LLC
    By:  

    /s/ Collin McBirney

      Collin McBirney
      Managing Member
    TOPLINE CAPITAL PARTNERS, LP
    By:   Topline Capital Management, LLC,
      its general partner
    By:  

    /s/ Collin McBirney

      Collin McBirney
      Managing Member
    COLLIN MCBIRNEY

    /s/ Collin McBirney

     

    8


    EXHIBIT LIST

     

    Exhibit A    Joint Filing Undertaking
    Get the next $PAYS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PAYS

    DatePrice TargetRatingAnalyst
    12/20/2024$6.00Buy
    Lake Street
    3/30/2022$4.00Mkt Perform
    Barrington Research
    3/24/2022Buy → Neutral
    Ladenburg Thalmann
    8/20/2021$3.50Neutral → Buy
    DA Davidson
    8/19/2021Neutral → Buy
    DA Davidson
    8/12/2021$3.50 → $3.75Neutral → Buy
    Ladenburg Thalmann
    More analyst ratings

    $PAYS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Strobo Robert was granted 100,000 shares, increasing direct ownership by 40% to 347,290 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    9/26/25 8:06:46 PM ET
    $PAYS
    EDP Services
    Technology

    CEO Newcomer Mark was granted 200,000 shares, increasing direct ownership by 2% to 8,950,728 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    9/26/25 8:06:31 PM ET
    $PAYS
    EDP Services
    Technology

    Chief Payments Officer Lanford Matthew Louis was granted 33,334 shares, increasing direct ownership by 23% to 180,698 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    9/26/25 8:06:14 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

    Garcia Tapped to Lead Strategy for Company's Life Science Solutions Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the life sciences industries, today announced that it has appointed Jose Garcia as Executive Vice President, Life Science Solutions. In his new role at Paysign, Mr. Garcia will implement and execute the market strategy for the company's comprehensive suite of engagement and management solutions targeting the life sciences industries. With more than two decades of executive experience in life sciences services, Mr. Garcia is a

    9/22/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced the opening of a new 30,000 square foot patient service support center in Henderson, Nevada. The facility increases Paysign's support capacity fourfold and will bolster the company's rapidly growing patient affordability business. The expansion reflects Paysign's strategic focus on scaling operations to meet rapidly growing demand from pharmaceutical manufacturers seeking more effective patient affordability solutions. This demand is being driven by Paysign's

    9/15/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. to Present at the Lake Street Best Ideas Growth BIG9 Conference

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be attending the ninth annual Lake Street Best Ideas Growth BIG9 Conference to be held Thursday, September 11, 2025. The conference is an annual invitation-only event, featuring dynamic, small-cap companies interacting with top institutional investors. The format has been designed to give attendees direct access to senior management via one-on-one and group meeting formats. Paysign's Chief Financial Officer, Jeff Baker, will be presenting to inves

    9/3/25 4:30:00 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Henry Daniel R bought $50,000 worth of shares (10,084 units at $4.96), increasing direct ownership by 8% to 129,884 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    6/16/25 9:00:04 PM ET
    $PAYS
    EDP Services
    Technology

    Director Henry Daniel R bought $67,716 worth of shares (19,800 units at $3.42), increasing direct ownership by 25% to 99,800 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/28/25 8:07:31 PM ET
    $PAYS
    EDP Services
    Technology

    Mina Bruce A bought $5,801 worth of shares (1,206 units at $4.81), increasing direct ownership by 0.56% to 218,500 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/15/24 6:19:59 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    SEC Filings

    View All

    Paysign Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Paysign, Inc. (0001496443) (Filer)

    9/15/25 9:01:05 PM ET
    $PAYS
    EDP Services
    Technology

    SEC Form 10-Q filed by Paysign Inc.

    10-Q - Paysign, Inc. (0001496443) (Filer)

    8/6/25 8:04:06 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Paysign, Inc. (0001496443) (Filer)

    8/5/25 4:06:19 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on PaySign with a new price target

    Lake Street initiated coverage of PaySign with a rating of Buy and set a new price target of $6.00

    12/20/24 8:45:02 AM ET
    $PAYS
    EDP Services
    Technology

    Barrington Research initiated coverage on PaySign with a new price target

    Barrington Research initiated coverage of PaySign with a rating of Mkt Perform and set a new price target of $4.00

    3/30/22 8:15:53 AM ET
    $PAYS
    EDP Services
    Technology

    PaySign downgraded by Ladenburg Thalmann

    Ladenburg Thalmann downgraded PaySign from Buy to Neutral

    3/24/22 7:30:30 AM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Leadership Updates

    Live Leadership Updates

    View All

    Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

    Garcia Tapped to Lead Strategy for Company's Life Science Solutions Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the life sciences industries, today announced that it has appointed Jose Garcia as Executive Vice President, Life Science Solutions. In his new role at Paysign, Mr. Garcia will implement and execute the market strategy for the company's comprehensive suite of engagement and management solutions targeting the life sciences industries. With more than two decades of executive experience in life sciences services, Mr. Garcia is a

    9/22/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer

    Paysign Strengthens Leadership in Technology for Plasma and Pharmaceutical Industries  Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has acquired the assets of Gamma Innovation LLC (Gamma), significantly enhancing Paysign's capabilities in plasma donor and pharmaceutical patient engagement technologies. As part of this strategic acquisition, Paysign has appointed Michael Ngo, former Managing Member of Gamma, as its Chief Innovation Officer. "This acquisition represents an exciting milestone for Paysign as we accelerate our growth strategy and expand our

    3/25/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Financials

    Live finance-specific insights

    View All

    Paysign, Inc. Reports Second Quarter 2025 Financial Results

    Second quarter 2025 total revenues of $19.08 million, up 33.1% from second quarter 2024 Second quarter 2025 net income of $1.39 million, up 99.1% from $697 thousand a year ago, while diluted earnings per share was $0.02, versus $0.01 for second quarter 2024 Second quarter 2025 Adjusted EBITDA of $4.51 million, up 101.8% from $2.24 million a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.04 for second quarter 20241 Added 123 net plasma centers during second quarter 2025, all which went live June 16. We exited the quarter with 607 centers; average monthly revenue per plasma center decreased to $7,098 compared to $7,916 for the same period last year; year-over-

    8/5/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Reports First Quarter 2025 Financial Results

    First quarter 2025 total revenues of $18.60 million, up 41.0% from first quarter 2024 First quarter 2025 net income of $2.59 million, or diluted earnings per share of $0.05, versus net income of $309 thousand, or diluted earnings per share of $0.01, for first quarter 2024 First quarter 2025 Adjusted EBITDA of $4.96 million, up 193.3% from $1.69 million a year ago, while diluted Adjusted EBITDA per share was $0.09 versus $0.03 for first quarter 20241 Total plasma center count increased by four net centers during first quarter 2025, exiting the quarter with 484 centers; revenue per plasma center decreased to $6,517 compared to $7,414 for the same period last year; year-over-year plasma

    5/8/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results

    For the Full-Year Full-year 2024 total revenues of $58.38 million, up 23.5% from full-year 2023 Full-year 2024 net income of $3.82 million, or diluted earnings per share of $0.07, versus net income of $6.46 million, or diluted earnings per share of $0.12 for full-year 2023 Full-year 2024 Adjusted EBITDA of $9.62 million, up 43.3% from $6.71 million a year ago, while diluted Adjusted EBITDA per share was $0.17 versus $0.12 for full-year 20231 Total plasma center count increased by 16 during 2024, exiting the year with 480 centers, contributing to a 4.6% increase in plasma revenue versus the same period last year Added 33 net patient affordability programs during 2024, exiting the y

    3/25/25 4:03:00 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Paysign Inc.

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    11/14/24 7:00:30 AM ET
    $PAYS
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    2/12/24 12:36:58 PM ET
    $PAYS
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    1/24/24 4:05:27 PM ET
    $PAYS
    EDP Services
    Technology